Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Anemia 4 Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Hematologic Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Transfusion Reaction 1 Thalassemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Patient Participation 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Hemorrhage 1 Carcinoma, Non-Small-Cell Lung 1 Bronchiolitis Obliterans Syndrome 1 Bone Marrow Failure Disorders 1 Anemia, Sickle Cell 1 Anemia, Aplastic 1

Interventions

fludarabine phosphate 4 fludarabine 4 Cyclophosphamide 4 Thiotepa 3 Melphalan 3 Whole-Body Irradiation 2 Tacrolimus 2 Surveys and Questionnaires 2 Fentanyl 2 Busulfan 2 Alemtuzumab 2 AP 1903 reagent 2 voxelotor 1 thymoglobulin 1 maltodextrin 1 Rituximab 1 Registries 1 Range of Motion, Articular 1 Protease Inhibitors 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Medical Marijuana 1 Interviews as Topic 1 Imagery, Psychotherapy 1 Holistic Health 1 Glutamine 1 Erythrocyte Count 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Anemia, Sickle Cell × Blood Transfusion × Clear all

NCT05255445 2024-05-17

RBC-IMPACT

Westat

Classical hematology

Anemia, Sickle Cell, Neoplasms, Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡